Article
HSP90 inhibitor gedunin impairs glioblastoma proliferation and invasiveness
medRxiv · 2023 · Costa, T. E. M. M.; Padua, T. A.; Pereira, J. X.; Rodrigues, V. G.; Seito, L. N.; Cunha, E. M.; Filgueiras, C. C.; Abreu-Villaca, Y.; Manhaes, A. C.; Maya-Monteiro, C. M.; Henriques, M. d. G.; Krahe, T. E.; Penido, C.
Key facts
| Title | HSP90 inhibitor gedunin impairs glioblastoma proliferation and invasiveness |
|---|---|
| First author | Costa, T. E. M. M.; Padua, T. A.; Pereira, J. X.; Rodrigues, V. G.; Seito, L. N.; Cunha, E. M.; Filgueiras, C. C.; Abreu-Villaca, Y.; Manhaes, A. C.; Maya-Monteiro, C. M.; Henriques, M. d. G.; Krahe, T. E.; Penido, C. |
| Journal | medRxiv |
| Published | Oct 16, 2023 |
| DOI | 10.1101/2023.06.02.543101 |
| Devices mentioned | K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186, K854187 and 1 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 2 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1